22 series
Export
<<< of 2>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterDavid Langlais
GSE180075
Type I interferon limits ILC2 effector functions through suppression of the CCR8-CCL1/CCL8 axis
10 David Langlais Jan 15, 2025
GSE266052
Cytokine Priming Enhances the Antifibrotic Effects of Mesenchymal Stromal Cells Conditioned Medium Via Fibrogenic Myofibroblasts Elimination and Extracellular Matrix Degradation.
20 David Langlais Oct 15, 2024
GSE249342
CCDC88B interacts with RASAL3 and ARHGEF2 to regulate dendritic cell function in neuroinflammation and colitis
2 David Langlais Jan 17, 2024
GSE221454
Thermoneutrality and severe malaria: investigating the effect of warmer environmental temperatures on the inflammatory response and disease progression
17 David Langlais May 24, 2023
GSE216486
Human IRF1 governs phagocytic IFN-γ immunity to mycobacteria but not cell-intrinsic IFN-a/b immunity to viruses [scRNAseq]
2 David Langlais Jan 12, 2023
GSE216488
Human IRF1 governs phagocytic IFN-γ immunity to mycobacteria but not cell-intrinsic IFN-a/b immunity to viruses [CITEseq]
10 David Langlais Jan 12, 2023
GSE216489
Human IRF1 governs phagocytic IFN-γ immunity to mycobacteria but not cell-intrinsic IFN-a/b immunity to viruses
12 David Langlais Jan 12, 2023
GSE200222
Leishmania parasites exchange drug-resistance genes through extracellular vesicles
6 David Langlais Jul 19, 2022
GSE176055
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
17 David Langlais Apr 05, 2022
GSE189385
The Role of Leishmania GP63 in Modulation of Innate Inflammatory Response to Leishmania major Infection
12 David Langlais Jan 01, 2022
GSE167185
Inherited human c-REL deficiency disrupts adaptive immunity
11 David Langlais Aug 31, 2021
GSE150663
MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction I.
8 David Langlais Jul 28, 2020
GSE150666
MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction II.
24 David Langlais Jul 28, 2020
GSE150667
MYSM1
61 David Langlais Jul 24, 2020
GSE150665
Repression of p53-target gene Bbc3/puma by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance
29 David Langlais Jul 22, 2020
GSE142069
ZBTB7B (ThPOK) IS REQUIRED FOR PATHOGENESIS OF CEREBRAL MALARIA AND PROTECTION AGAINST PULMONARY TUBERCULOSIS
2 David Langlais Dec 17, 2019
GSE79702
USP15 regulates type I interferon response in vivo and is required for pathogenesis of microbial and autoimmune neuroinflammation
25 David Langlais Oct 10, 2016
GSE77884
The macrophage IRF8-IRF1 regulome is required for protection against infections, and is associated with chronic inflammation (ChIP-Seq)
17 David Langlais Mar 07, 2016
GSE77885
The macrophage IRF8-IRF1 regulome is required for protection against infections, and is associated with chronic inflammation (RNA-Seq)
12 David Langlais Mar 07, 2016
GSE77886
The macrophage IRF8-IRF1 regulome is required for protection against infections, and is associated with chronic inflammation
29 David Langlais Mar 03, 2016